Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Perrigo Shares Dropped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of generic-drug maker Perrigo (Nasdaq: PRGO  ) were making investors ill today, falling as much as 10% after a disappointing earnings report.

So what: A top-line miss was the big news here. Perrigo managed to grow sales 18% to $832 million, but that was well short of the $856 million analysts were expecting. Earnings per share came in $0.02 ahead of the experts at $1.28, however, and the company provided full-year guidance of $5.30 to $5.50, indicating a slowdown from its previous fast-paced growth. Management did not acknowledge any weakness in its press release, and pointed to opportunities in its acquisition of CanAm Care, newly signed supply agreements for infant formula in China, and other new product launches as well.

Now what: Investors may be justified in their concern about Perrigo's long-term growth after today's revenue miss. EPS guidance for next year only represents an increase of 6% to 10%, which seems low for a company with a P/E around 22. If this pharmaceutical continues to miss sales expectations in upcoming quarters, that should be a sign for investors that it's time to check out.

Want to make sure you get your daily dose of Perrigo? Just add Perrigo to your watchlist.

Fool contributor Jeremy Bowman holds no positions in the companies in this article. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1987195, ~/Articles/ArticleHandler.aspx, 10/26/2016 3:49:52 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:02 PM
PRGO $90.17 Down -0.44 -0.49%
Perrigo CAPS Rating: ****